- Home
- ORMP vs HUMAW Comparison
ORMP vs HUMAW Comparison
Compare ORMP & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- HUMAW
- Stock Information
- Founded
- ORMP 2002
- HUMAW 2004
- Country
- ORMP United States
- HUMAW United States
- Employees
- ORMP N/A
- HUMAW 220
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- HUMAW Health Care
- Exchange
- ORMP Nasdaq
- HUMAW Nasdaq
- Market Cap
- ORMP 93.9M
- HUMAW N/A
- IPO Year
- ORMP N/A
- HUMAW N/A
- Fundamental
- Price
- ORMP $2.27
- HUMAW $0.19
- Analyst Decision
- ORMP
- HUMAW
- Analyst Count
- ORMP 0
- HUMAW 0
- Target Price
- ORMP N/A
- HUMAW N/A
- AVG Volume (30 Days)
- ORMP 91.7K
- HUMAW 14.2K
- Earning Date
- ORMP 11-06-2025
- HUMAW 03-21-2025
- Dividend Yield
- ORMP N/A
- HUMAW N/A
- EPS Growth
- ORMP N/A
- HUMAW N/A
- EPS
- ORMP N/A
- HUMAW N/A
- Revenue
- ORMP $2,000,000.00
- HUMAW N/A
- Revenue This Year
- ORMP N/A
- HUMAW N/A
- Revenue Next Year
- ORMP N/A
- HUMAW N/A
- P/E Ratio
- ORMP N/A
- HUMAW N/A
- Revenue Growth
- ORMP N/A
- HUMAW N/A
- 52 Week Low
- ORMP $1.82
- HUMAW $1.18
- 52 Week High
- ORMP $3.09
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- ORMP 54.03
- HUMAW N/A
- Support Level
- ORMP $2.17
- HUMAW N/A
- Resistance Level
- ORMP $2.45
- HUMAW N/A
- Average True Range (ATR)
- ORMP 0.06
- HUMAW 0.00
- MACD
- ORMP 0.01
- HUMAW 0.00
- Stochastic Oscillator
- ORMP 43.75
- HUMAW 0.00
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.